CIBC World Market’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$722K Buy
+4,811
New +$523K ﹤0.01% 1103
2024
Q1
Sell
-9,106
Closed -$246K 1331
2023
Q4
$246K Buy
9,106
+657
+8% +$17.2K ﹤0.01% 1123
2023
Q3
$250K Buy
8,449
+509
+6% +$17.9K ﹤0.01% 1074
2023
Q2
$284K Buy
+7,940
New +$228K ﹤0.01% 1061
2023
Q1
Sell
-14,444
Closed -$393K 1285
2022
Q4
$393K Buy
+14,444
New +$661K ﹤0.01% 984

Other funds holding GH

CIBC World Market's GH Position: Q2 2026 in Review

CIBC World Market opened a new position in Guardant Health (GH) in Q2 2026: 4,811 shares worth $722K. The stake represents ﹤0.01% of the portfolio and ranks #1103 among its holdings. This is a return to the name: CIBC World Market previously reported a position in GH as recently as Q4 2023.

CIBC World Market first reported a position in GH in Q4 2022 and has held it in 5 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • CIBC World Market held 4,811 shares of Guardant Health worth $722K as of Q2 2026.
  • Guardant Health was a new CIBC World Market position in Q2 2026.
  • Guardant Health made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1103 holding.
  • CIBC World Market first reported a position in Guardant Health in Q4 2022 and has held it in 5 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.